Skip to main content
×
×
Home

Nicotine: Pharmacology, Toxicity and Therapeutic use

  • Karl Fagerström (a1)
Extract

Nicotine is naturally found in the plants belonging to the Solanaceae family. Concentrations high enough to have a pharmacological effect are seen only in the tobacco sub-family, approximately 2% of dry weight and in Duboisia Hopwoodii that has been used by Australian aborigines (http://en.wikipedia.org/wiki/Duboisia_hopwoodii). It is also present in the range of 2–7 microgram per kg of various edible plants.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nicotine: Pharmacology, Toxicity and Therapeutic use
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Nicotine: Pharmacology, Toxicity and Therapeutic use
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Nicotine: Pharmacology, Toxicity and Therapeutic use
      Available formats
      ×
Copyright
References
Hide All
Anfang, M. K., & Pope, H. Jr. (1997). Treatment of neuroleptically-induced akathisia with nicotine patches. Psychopharmacology, 134, 153156.
ASH (Action on Smoking, Health) (2007). Nicotine replacement therapy guidelines for healthcare professionals on using nicotine replacement therapy for smokers not yet ready to stop smoking. (17 pp.). ASH (Action on Smoking, Health) (2012). E-cigarette use in Great Britain: 2010 and 2012.
Baba, S., Wikström, A. K., Stephansson, O., & Cnattingius, S. (2013). Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG: An International Journal of Obstetrics & Gynaecology, 120 (4), 456462. doi: 10.1111/1471-0528.12067. Epub 2012 Nov 27.
Barr, R. S., Culhane, M. A., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P.et al. (2008). The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology, 33 (3), 480490. Epub 2007 Apr 18.
Barrett, S. P. (2010). The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers. Behavioural Pharmacology, 21, 144152. doi:10.1097/FBP.0b013e328337be68.
Baum, S. S., Hill, R., & Rommelspacher, H. (1996). Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. European Journal of Pharmacology, 314, 7582. doi:10.1016/S0014-2999(96)00543-2.
Beard, E., McDermott, M., McEwen, A., & West, R. (2012). Beliefs of stop smoking practitioners in United Kingdom on the use of nicotine replacement therapy for smoking reduction. Nicotine & Tobacco Research, 14 (1469–994X (Electronic)), 639647. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22180579. Accessed October 10, 2012.
Benowitz, N. L., Hansson, A., & Jacob, P. I. (2002). Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension, 39 (1524–4563 (Electronic)), 11071112.
Benwell, M. E. M., Balfour, D., & Birrell, C. E. (1995). Desensitization of nicotine-induced mesolimbic dopamine response during constant infusion with nicotine. British Journal of Pharmacology, 114, 454460.
Brennan, K. A., Crowther, A., Putt, F., Roper, V., Waterhouse, U., & Truman, P. (2013). Tobacco particulate matter self-administration in rats: Differential effects of tobacco type. Add Biology, doi:10.1111/adb.12099.
Brody, A. L., Mandelkern, M. A., Costello, M. R., Abrams, A. L., Scheibal, D., Farahi, J.et al. (2009). Brain nicotinic acetylcholine receptor occupancy effect of smoking a denicotinized cigarette. International Journal of Neuropsychopharmacology, 12, 305316. doi:10.1017/S146114570800922X.
Buchhalter, A. R., Acosta, M. C., Evans, S. E., Breland, B., & Eissenberg, T. (2005). Tobacco abstinence symptom suppression: The role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction, 100, 550559. doi:10.1111/j.1360-0443.2005.01030.x.
Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006). Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl), Mar, 184 (3–4), 353366. Epub 2005 Oct 21. Review.
Chen, R. J., Ho, Y. S., Guo, H. R., & Wang, Y. J. (2008b). Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicological Sciences, 104 (2), 283293.
Clemens, K. J., Cailille, S., Stinus, L., & Cador, M. (2009). The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. International Journal of Psychopharmacology, 12, 13551366. doi:10.1017/S1461145709000273.
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T.et al. (2009). 2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Archives of General Psychiatry, 66 (6), 666676.
Cummings, K. M., Hyland, A., Giovino, G. A., Hastrup, J. L., Bauer, J. E., & Bansal, M.A. (2004). Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine & Tobacco Research, 6 Suppl 3(December), S333S340. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15799596.
Dale, L. C., Hurt, R. D., Offord, K. P., Lawson, G. M., Croghan, I. T., & Schroeder, D. R. (1995). High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. Journal of the American Medical Association, 274, 13531358. doi:10.1001/jama.1995.0353017003.
DiFranza, J., & Ursprung, W. W. (2010). A systematic review of the international classification of diseases criteria for the diagnosis of tobacco dependence. Addictive Behaviors, 35, 805810. doi:10.1016/j.addbeh.2010.04.002.
EU Barometer 385. Available at: http://ec.europa.eu/public_opinion/index_en.htm.
Fagerstrom, K., & Eissenberg, T. (2012). Dependence on tobacco and nicotine products: A case for product-specific assessment. Nicotine & Tobacco Research, 14, 13821390. doi: 10.1093/ntr/nts007.
Fagerström, K. O., & Pomerleau, O. (1994). Nicotine may relieve symptoms of parkinsons disease. Psychopharmacology, 116, 117119.
Fiore, M.C., Jaen, C.R., Baker, T.B., Bailey, W.C., Benowitz, N., Curry, S.J.et al. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Retrieved from http://www.ahrq.gov/path/tobacco.htm#Clinic.
Fiore, M. C., Schroeder, S. A., & Baker, T. B. (2014). Smoke, the chief killer — strategies for targeting combustible Tobacco use. New England Journal of Medicine, 370, 297299. January 23, 2014, doi: 10.1056/NEJMp1314942.
Fowler, J. S., Logan, J., Wang, G. J., Volkow, N. D., Telang, F., Zhu, W.et al. (2003). Low monoamine oxidase B in peripheral organs in smokers. Proceedings of the National Academy of Sciences of the United States of America, 30, 11600–11605. doi:10.1073/pnas.1833106100.
Fowler, J.S., Wang, G. J., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N.et al. (1999). Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers. Nicotine & Tobacco Research, 1, 325329. doi:10.1080/14622299050011451.
Gehricke, J. G., Hong, N., Whalen, C. K., Steinhoff, K., & Wigal, T. L. (2009). Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder. Psychology of Addictive Behaviors, Dec, 23 (4), 644655. doi: 10.1037/a0017441.
Green, J.T., Thomas, G.A., Rhodes, J., Williams, G.T., Evans, B.K., Russell, M.A.et al. (1997). Nicotine enemas for active ulcerative colitis–a pilot study. Alimentary Pharmacology & Therapeutics, Oct, 11 (5), 859863.
Greenland, S., Satterfield, M. H., & Lanes, S. F. (1998). A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 18 (4), 297308. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9565740. Accessed October 10, 2012.
Hansson, J., Galanti, M. R., Hergens, M.-P., Fredlund, P., Ahlbom, A., Alfredsson, L.et al. (2012). Use of snus and acute myocardial infarction: Pooled analysis of eight prospective observational studies. European Journal of Epidemiology, Oct, 27 (10), 771779. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22722951. Accessed October 9, 2012.
Hedstrom, A. K., Hillert, J., Olsson, T., & Alfredsson, T. (2013). Nicotine might have a neuroprotective effect in the etiology of multiple sclerosis. Multiple Sclerosis, Jul, 19 (8), 10091013. doi: 10.1177/1352458512471879. Epub 2013 Jan 14.
Hergens, M. P., Alfredsson, L., Bolinder, G., Lambe, M., Pershagen, G., & Ye, W. (2007). Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. Journal of Internal Medicine, 262 (0954–6820 (Print)), 351359.
Hubbard, R., Lewis, S., Smith, C., Godfrey, C., Smeeth, L., Farrington, P.et al. (2005). Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tobacco Control, 14 (6), 416421. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1748112&tool=pmcentrez&rendertype=abstract. Accessed October 9, 2012.
Hughes, J. R., Rose, G. L., & Callas, P. W. (2000). Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Alcoholism: Clinical and Experimental Research, 24, 16331638. doi:10.1111/j.1530-0277.2000.tb01964.x.
International Agency for Research on Cancer (2004). Tobacco smoke and involuntary smoking. IACR Monograph, Volume 83. Lyon; 2004, 1452 pp. Available at: http://monographs.iarc.fr/ENG/Monographs/vol83/index.php.
International Agency for Research on Cancer (2007). Some tobacco-specific N-nitrosamines. IACR Monograph, Volume 89, 583.
Jacob, P. 3rd, Benowitz, N. L., & Shulgin, A. T. (1988). Recent studies of nicotine metabolism in humans. Pharmacology Biochemistry Behavior, 30 (1), 249253.
Joseph, A., Norman, S., Ferry, L., Prochazka, A. V., Westman, E. C., Steele, B. G.et al. (1996). The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. The New England Journal of Medicine, 335, 17921798.
Kimmel, S. E., Berlin, J. A., Miles, C., Jaskowiak, J., Carson, J. L., & Strom, B. L. (2001). Risk of acute first myocardial infarction and use of nicotine patches in a general population. Journal of the American College of Cardiology, 37 (5), 12971302. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11300438.
Kloosterman, K. (2013). Electronic cigarette kills toddler in Israel. Green Prophet, 29 May. 2013. Available at: http://www.greenprophet.com/2013/05/electronic-cigarette-kills-toddler-in-israel/ (accessed 4 April 2014) (Archived at http://www.webcitation.org/6QnAb1lS9 on 3 July 2014).
Lee, J., & Cooke, J. P. (2012). Nicotine and pathological angiogenesis. Life Sciences, 91 (21–22), 10581064.
Lee, P. N. (2007). Circulatory disease and smokeless tobacco in Western populations: A review of the evidence. International Journal of Epidemiology, 36 (4), 789804. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17591642. Accessed October 9, 2012.
Lee, P. N. (2011). Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology, 59 (1096–0295 (Electronic)), 197214.
Lewin, F., Norell, S. E., Johansson, H.et al. (1998). Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: A population-based case-referent study in Sweden. Cancer, 82 (7), 13671375. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9529030. Accessed February 11, 2013.
Lopez, A. D., Christopher, J. L., Murray, M. D., Gakidou, E., Mathers, C. D., Ezzati, M.et al. (2006). Global burden of disease and risk factors. Washington DC: The World Bank Group and New York: Oxford University Press, 2006. www.dcp2.org/pubs/GBD (accessed 7 August 2007).
Lunell, E., & Lunell, M. (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study. Nicotine & Tobacco Research, 7 (3), 397403.
Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H. O., Boffetta, P.et al. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study. Lancet, 369 (1474–547X (Electronic)), 20152020.
McClernon, F. J., Hiott, F. B., Westman, E. C., Rosse, J. E., & Levin, E. D. (2006). Transdermal nicotine attenuates depression symptoms in non-smokers: A double blind, placebo controlled trial. Psychopharmacology, 189, 125133.
Meyer, B. (2013). How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives of Toxicology, 88, 57. 10.1007/s00204-013-1127-0.
Murray, R. P., Connett, J. E., & Zapawa, L. M. (2009). Does nicotine replacement therapy cause cancer? Evidence from the Lung Health Study. Nicotine & Tobacco Research: Official journal of the Society for Research on Nicotine and Tobacco, 11 (9), 10761082. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2725009&tool=pmcentrez&rendertype=abstract. Accessed October 9, 2012.
Newhouse, P., Kellar, K., Aisen, P., White, H., Wesnes, K., Coderre, E.et al. (2012). Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial. Neurology, Jan 10, 78 (2), 91101. doi: 10.1212/WNL.0b013e31823efcbb.
Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B.et al. (2014). Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. Journal of American Medical Association, 311 (2), 183192. doi:10.1001/jama.2013.284692.
O’Reilly, E. J., McCullough, M. L., Chao, A., Henley, S. J., Calle, E. E., Thun, M. J.et al. (2005). Smokeless tobacco use and the risk of Parkinson's disease mortality. Movement Disorders, 20 (10), 13831384.
Pauly, J. R., & Slotkin, T. A. (2008). Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatrica, 97 (10), 13311337. doi: 10.1111/j.1651-2227.2008.00852.x. Epub 2008 Jun 12.
Perkins, K. A. (1993). Weight gain following smoking cessation. Journal of Consulting and Clinical Psychology, 61, 768777.
Perkins, K. A., Gerlach, D., Broge, M., Fonte, C., & Wilson, A. (2001). Reinforcing effects of nicotine as a function of smoking status. Experimental and Clinical Pharmacology, 9, 243250. doi:10.1037/1064-1297.9.3.243.
Peto, R., Lopez, A. D., Boreham, J., Thun, M., Heath, C. Jr., & Doll, R. (1996). Mortality from smoking worldwide. British Medical Bulletin, 52 (1), 1221.
Rodd, Z. A., Bell, R. L., Zhang, Y., Goldstein, A., Zaffaroni, A., McBride, W. J.et al. (2003). Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P)rats. Alcoholism Clinical and Experimental Research, 27, 440449. doi:10.1097/01.ALC.0000056612.89957.B4.
Sandborn, W. J. (1999). Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results. The American Journal of Gastroenterology, 94 (5), 11611171. Review.
Schildt, E. B., Eriksson, M., Hardell, L., & Magnuson, A. (1998). Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. International Journal of Cancer. Journal International du Cancer, 77 (3), 341346. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9663593. Accessed February 11, 2013.
Sherwood, N. (1993). Effects of nicotine on human psychomotor performance. Human Psychopharmacology, 8, 155184.
Sieber, M. (2012). Neuroprotective properties of nicotine. Current Medicinal Chemistry, 19 (2), 292297.
Silver, A. A., Shytle, R. D., Philipp, M. K., Wilkinson, B. J., McConville, B., & Sanberg, P. R. (2001). Transdermal nicotine and haloperidol in Tourette's disorder: A double-blind placebo-controlled study. Journal of Clinical Psychiatry, 62 (9), 707714.
Thiriez, C., Villafane, G., Grapin, F., Fenelon, G., Remy, P., & Cesaro, P. (2011). Can nicotine be used medicinally in Parkinson's disease? Expert Review of Clinical Pharmacology, Jul, 4 (4), 429436. doi: 10.1586/ecp.11.27. Review.
Ulrich, Y.M., Hargreaves, K.M., & Flores, C.M. (1997). A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites. Neuropharmacology, 36, 11191125.
US Department of Health and Human Services (1988). The health consequences of smoking. Nicotine addiction: A Report of the Surgeon-General. Rockville, MD: Author.
US Department of Health and Human Services (2014). The health consequences of smoking—50 years of progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014.
Villegier, A. S., Blanc, G., Glowinski, J., & Tassin, J. P. (2003). Transient behavioural sensitization to nicotine becomes long lasting with monoamine oxidase inhibitors. Pharmacology Biochemistry & Behaviour, 76, 267274. doi:10.1016/S0091-3057(03)00223-5.
Wikström, A. K., Cnattingius, S., & Stephansson, O. (2010a). Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology, 21 (1531–5487 (Electronic)), 772778.
Wikström, A. K., Stephansson, O., & Cnattingius, S. (2010b). Tobacco use during pregnancy and preeclampsia risk: Effects of cigarette smoking and snuff. Hypertension, 55 (1524–4563 (Electronic)), 12541259.
Wilbert, J. (1993). Tobacco and Shamanism in South America ISBN 0-300-05790-3.
Wolf, R., Orion, E., Matz, H., Maitra, S., & Rowland-Payne, C. (2004). Smoking can be good for you. Journal of Cosmetic Dermatology, 3 (2), 107111.
Zendehdel, K., Nyren, O., Luo, J., Dickman, P.W., Boffetta, P., Englund, A.et al. (2008). Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. International Journal of Cancer, 122 (1097–0215 (Electronic)), 10951099.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Smoking Cessation
  • ISSN: -
  • EISSN: 1834-2612
  • URL: /core/journals/journal-of-smoking-cessation
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed